39 related articles for article (PubMed ID: 38744861)
1. Raman Spectroscopy of Head and Neck Cancer: Separation of Malignant and Healthy Tissue Using Signatures Outside the "Fingerprint" Region.
Holler S; Mansley E; Mazzeo C; Donovan MJ; Sobrero M; Miles BA
Biosensors (Basel); 2017 May; 7(2):. PubMed ID: 28505107
[TBL] [Abstract][Full Text] [Related]
2. Infrared spectroscopy for fast screening of diabetes and periodontitis.
da Silva SMSD; Ferreira CL; Rizzato JMB; Toledo GDS; Furukawa M; Rovai ES; Nogueira MS; Carvalho LFDCES
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104106. PubMed ID: 38677501
[TBL] [Abstract][Full Text] [Related]
3. Decision-level data fusion based on laser-induced breakdown and Raman spectroscopy: A study of bimodal spectroscopy for diagnosis of lung cancer at different stages.
Lin J; Li Y; Lin X; Che C
Talanta; 2024 Aug; 275():126194. PubMed ID: 38703481
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue.
Kanmalar M; Kamal R; Abdul Sani SF; Pathmanathan D; Bm Said NA; Paramanantham Y; Abd Jamil AH; Mun KS; Kuppusamy S; Almugren KS; Almajid HF; Bradley DA
Appl Radiat Isot; 2024 May; 210():111372. PubMed ID: 38810354
[TBL] [Abstract][Full Text] [Related]
5. FT-Raman and FTIR spectroscopy as a tools showing marker of platinum-resistant phenomena in women suffering from ovarian cancer.
Kluz-Barłowska M; Kluz T; Paja W; Pancerz K; Łączyńska-Madera M; Miziak P; Cebulski J; Depciuch J
Sci Rep; 2024 May; 14(1):11025. PubMed ID: 38744861
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Cancer-Insights into Platinum Resistance and Overcoming It.
Havasi A; Cainap SS; Havasi AT; Cainap C
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984544
[TBL] [Abstract][Full Text] [Related]
7. Molecular features as promising biomarkers in ovarian cancer.
Bukłaho PA; Kiśluk J; Wasilewska N; Nikliński J
Adv Clin Exp Med; 2023 Sep; 32(9):1029-1040. PubMed ID: 36920264
[TBL] [Abstract][Full Text] [Related]
8. Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers.
Atallah GA; Kampan NC; Chew KT; Mohd Mokhtar N; Md Zin RR; Shafiee MNB; Abd Aziz NHB
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768291
[TBL] [Abstract][Full Text] [Related]
9. Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer.
Sassu CM; Palaia I; Boccia SM; Caruso G; Perniola G; Tomao F; Di Donato V; Musella A; Muzii L
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948446
[TBL] [Abstract][Full Text] [Related]
10. 2020 WHO Classification of Female Genital Tumors.
Höhn AK; Brambs CE; Hiller GGR; May D; Schmoeckel E; Horn LC
Geburtshilfe Frauenheilkd; 2021 Oct; 81(10):1145-1153. PubMed ID: 34629493
[TBL] [Abstract][Full Text] [Related]
11. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer.
Ghoneum A; Almousa S; Warren B; Abdulfattah AY; Shu J; Abouelfadl H; Gonzalez D; Livingston C; Said N
Semin Cancer Biol; 2021 Dec; 77():83-98. PubMed ID: 33476723
[TBL] [Abstract][Full Text] [Related]
12. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
13. Raman and Fourier transform infrared imaging for characterization of bone material properties.
Taylor EA; Donnelly E
Bone; 2020 Oct; 139():115490. PubMed ID: 32569874
[TBL] [Abstract][Full Text] [Related]
14. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.
Zhou J; Kang Y; Chen L; Wang H; Liu J; Zeng S; Yu L
Front Pharmacol; 2020; 11():343. PubMed ID: 32265714
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Analysis of Saliva for Breast Cancer Diagnosis.
Ferreira ICC; Aguiar EMG; Silva ATF; Santos LLD; Cardoso-Sousa L; Araújo TG; Santos DW; Goulart LR; Sabino-Silva R; Maia YCP
J Oncol; 2020; 2020():4343590. PubMed ID: 32104176
[TBL] [Abstract][Full Text] [Related]
16. Mesothelin as a biomarker for targeted therapy.
Lv J; Li P
Biomark Res; 2019; 7():18. PubMed ID: 31463062
[TBL] [Abstract][Full Text] [Related]
17. Applications of Raman spectroscopy in cancer diagnosis.
Auner GW; Koya SK; Huang C; Broadbent B; Trexler M; Auner Z; Elias A; Mehne KC; Brusatori MA
Cancer Metastasis Rev; 2018 Dec; 37(4):691-717. PubMed ID: 30569241
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing Ewing sarcoma and osteomyelitis using FTIR spectroscopy.
Chaber R; Arthur CJ; Depciuch J; Łach K; Raciborska A; Michalak E; Cebulski J
Sci Rep; 2018 Oct; 8(1):15081. PubMed ID: 30305666
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
